HUMAN PD-L2 TRIGGERS A UNIQUE T CELL INHIBITORY PROGRAM THROUGH PD-1 ENGAGEMENT DISTINCT FROM THAT OF PD-L1

被引：0
|
作者：
Srinivasamani, Anupallavi [1 ]
Curran, Michael [1 ]
Liu, Qinying [2 ]
Hegde, Shwetha [1 ]
Chen, Chao-Hsien [1 ]
Rajapakshe, Kimal [3 ]
Coarfa, Cristian
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Fudan Univ, Shanghai, Peoples R China
[3] Baylor Coll Med, Houston, TX 77030 USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2021年 / 9卷
关键词：
D O I：
10.1136/jitc-2021-SITC2021.233
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
233
引用
收藏
页码：A248 / A248
页数：1
相关论文
共 50 条
  • [31] EXPRESSION OF PD-1, PD-L1 AND PD-L2 IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES AND ITS CLINIC RELATIONSHIP
    Geng, S.
    Weng, J.
    Deng, C.
    Li, M.
    Lu, Z.
    Wu, P.
    Huang, X.
    Lai, P.
    Du, X.
    LEUKEMIA RESEARCH, 2017, 55 : S112 - S112
  • [32] High-affinity PD-1 molecules deliver improved interaction with PD-L1 and PD-L2
    Li, Yanyan
    Liang, Zhaoduan
    Tian, Ye
    Cai, Wenxuan
    Weng, Zhiming
    Chen, Lin
    Zhang, Huanling
    Bao, Yifeng
    Zheng, Hongjun
    Zeng, Sihai
    Bei, Chunhua
    Li, Yi
    CANCER SCIENCE, 2018, 109 (08): : 2435 - 2445
  • [33] Regulation of PD-1/PD-L1 pathway and resistance to PD-1/PD-L1 blockade
    Bai, Jie
    Gao, Zhitao
    Li, Xiang
    Dong, Liang
    Han, Weidong
    Nie, Jing
    ONCOTARGET, 2017, 8 (66) : 110693 - 110707
  • [34] The role of antagonists of the PD-1: PD-L1/PD-L2 axis in head and neck cancer treatment
    Pai, Sara I.
    Zandberg, Dan P.
    Strome, Scott E.
    ORAL ONCOLOGY, 2016, 61 : 152 - 158
  • [35] Evaluation of PD-L1, PD-L2, PD-1 and cytotoxic immune response in oral lichen planus
    Costa, Nadia Lago
    Goncalves, Julie Ane Maria
    de Lima, Sara Lia Goncalves
    de Arruda, Jose Alcides Almeida
    Miranda, Ana Carolina Campos
    Mesquita, Ricardo Alves
    da Silveira, Ericka Janine Dantas
    Batista, Aline Carvalho
    ORAL DISEASES, 2020, 26 (06) : 1246 - 1254
  • [36] AKT/mTOR Signal Cascade and Expression of PD-1, PD-L1, and PD-L2 in Gastric Cancer
    L. V. Spirina
    A. V. Avgustinovich
    S. G. Afanas’ev
    I. V. Kondakova
    M. Yu. Volkov
    A. Yu. Dobrodeev
    A. I. Boronkina
    Bulletin of Experimental Biology and Medicine, 2020, 170 : 75 - 78
  • [37] Differential expressions of PD-1, PD-L1 and PD-L2 between primary and metastatic sites in renal cell carcinoma
    Xingming Zhang
    Xiaoxue Yin
    Haoran Zhang
    Guangxi Sun
    Yaojing Yang
    Junru Chen
    Xudong Zhu
    Peng Zhao
    Jinge Zhao
    Jiandong Liu
    Ni Chen
    Jia Wang
    Pengfei Shen
    Hao Zeng
    BMC Cancer, 19
  • [38] Immune Checkpoint (PD-1, PD-L1, PD-L2, and CTLA-4) Expression in Plasma Cell Myeloma
    Lee, Min Young
    Park, Chan-jeoung
    Cho, Young-Uk
    You, Eunkyoung
    Jang, Seongsoo
    Lee, Jung-Hee
    Hong, Jung Yong
    Yoon, Dok Hyun
    Suh, Cheolwon
    BLOOD, 2017, 130
  • [39] Differential expressions of PD-1, PD-L1 and PD-L2 between primary and metastatic sites in renal cell carcinoma
    Zhang, Xingming
    Yin, Xiaoxue
    Zhang, Haoran
    Sun, Guangxi
    Yang, Yaojing
    Chen, Junru
    Zhu, Xudong
    Zhao, Peng
    Zhao, Jinge
    Liu, Jiandong
    Chen, Ni
    Wang, Jia
    Shen, Pengfei
    Zeng, Hao
    BMC CANCER, 2019, 19 (1)
  • [40] Expression of PD-1/PD-L1 and PD-L2 in peripheral T-cells from non-small cell lung cancer patients
    Arrieta, Oscar
    Montes-Servin, Edgar
    Hernandez-Martinez, Juan-Manuel
    Cardona, Andres F.
    Casas-Ruiz, Eibar
    Crispin, Jose C.
    Motola, Daniel
    Flores-Estrada, Diana
    Barrera, Lourdes
    ONCOTARGET, 2017, 8 (60) : 101994 - 102005
12345